In this online, self-learning activity: Hemophilia is a genetic disease caused by mutation of one of the genes for coagulation proteins leading to dangerous, uncontrolled bleeding. In hemophilia B, a mutation in the gene for factor IX (FIX) leads to an endogenous deficiency in the clotting factor. The incidence of hemophilia B is the same across race and ethnic groups, affecting approximately 1 out of every 30,000 male births.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Address:
- 1935 8th Avenue
Pricing
100% of listed courses are free
52 of 52 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Cardiovascular Disease
- Endocrinology, Diabetes & Metabolism
- Gastroenterology
- General Internal Medicine
- General Pediatrics
- Hematology
- Medical Oncology
- Neonatal-Perinatal Medicine
- Nephrology
- Neurocritical Care
- Neurology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Neurology
- Pediatric Radiology
- Pediatric Transplant Hepatology
- Pulmonary Disease
- Rheumatology
- Transplant Hepatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pediatrics
- Primary care
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- includes Board review / self-assessment
- Credit · Up to 0.75 credits
- MOC · Up to 0.75 points
- Commercial Support
-
ReleasedFeb 17, 2026
-
Last day to claim creditFeb 18, 2027 4 months left
-
ScientiaCME Factoring updates in care and best practice into our management of hemophilia B
-
ScientiaCME From alpha to optimal: contemporary strategies for managing alpha thalassemia and its complications
-
ScientiaCME Setting it straight: transformative therapeutics in the management of sickle cell disease
